131 related articles for article (PubMed ID: 37121837)
1. Diabetes mellitus in patients with type 1 autoimmune pancreatitis at diagnosis and after corticosteroid therapy.
Li MZ; Guo T; Feng YL; Zhang SY; Bai XY; Wu X; Xu K; Yang AM
Hepatobiliary Pancreat Dis Int; 2024 Aug; 23(4):393-398. PubMed ID: 37121837
[TBL] [Abstract][Full Text] [Related]
2. Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.
Noguchi K; Nakai Y; Mizuno S; Isayama H; Hirano K; Kanai S; Nakamura T; Uchino R; Takahara N; Kogure H; Tada M; Koike K
J Gastroenterol; 2020 Feb; 55(2):198-204. PubMed ID: 31471733
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
[TBL] [Abstract][Full Text] [Related]
4. Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment.
Overbeek KA; Poulsen JL; Lanzillotta M; Vinge-Holmquist O; Macinga P; Demirci AF; Sindhunata DP; Backhus J; Algül H; Buijs J; Levy P; Kiriukova M; Goni E; Hollenbach M; Miksch RC; Kunovsky L; Vujasinovic M; Nikolic S; Dickerson L; Hirth M; Neurath MF; Zumblick M; Vila J; Jalal M; Beyer G; Frost F; Carrara S; Kala Z; Jabandziev P; Sisman G; Akyuz F; Capurso G; Falconi M; Arlt A; Vleggaar FP; Barresi L; Greenhalf B; Czakó L; Hegyi P; Hopper A; Nayar MK; Gress TM; Vitali F; Schneider A; Halloran CM; Trna J; Okhlobystin AV; Dagna L; Cahen DL; Bordin D; Rebours V; Mayerle J; Kahraman A; Rasch S; Culver E; Kleger A; Martínez-Moneo E; Røkke O; Hucl T; Olesen SS; Bruno MJ; Della-Torre E; Beuers U; Löhr JM; Rosendahl J;
Clin Gastroenterol Hepatol; 2024 May; 22(5):994-1004.e10. PubMed ID: 38184096
[TBL] [Abstract][Full Text] [Related]
5. The relationship between pancreatic atrophy after steroid therapy and diabetes mellitus in patients with autoimmune pancreatitis.
Masuda A; Shiomi H; Matsuda T; Takenaka M; Arisaka Y; Azuma T; Kutsumi H
Pancreatology; 2014; 14(5):361-5. PubMed ID: 25278305
[TBL] [Abstract][Full Text] [Related]
6. Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.
Nishimori I; Tamakoshi A; Kawa S; Tanaka S; Takeuchi K; Kamisawa T; Saisho H; Hirano K; Okamura K; Yanagawa N; Otsuki M;
Pancreas; 2006 Apr; 32(3):244-8. PubMed ID: 16628078
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis.
Ito T; Nakamura T; Fujimori N; Niina Y; Igarashi H; Oono T; Uchida M; Kawabe K; Takayanagi R; Nishimori I; Otsuki M; Shimosegawa T
J Dig Dis; 2011 Jun; 12(3):210-6. PubMed ID: 21615876
[TBL] [Abstract][Full Text] [Related]
8. Short and long-term outcomes of diabetes mellitus in patients with autoimmune pancreatitis after steroid therapy.
Miyamoto Y; Kamisawa T; Tabata T; Hara S; Kuruma S; Chiba K; Inaba Y; Kuwata G; Fujiwara T; Egashira H; Koizumi K; Sekiya R; Fujiwara J; Arakawa T; Momma K; Asano T
Gut Liver; 2012 Oct; 6(4):501-4. PubMed ID: 23170157
[TBL] [Abstract][Full Text] [Related]
9. The Role of Endoscopic Ultrasound-guided Drainage for Autoimmune Pancreatitis-associated Pancreatic Cysts: A Report of Five Cases and a Literature Review.
Yamamoto K; Itoi T; Sofuni A; Tsuchiya T; Tsuji S; Tanaka R; Tonozuka R; Honjo M; Mukai S; Kamada K; Fujita M; Asai Y; Matsunami Y; Nagakawa Y
Intern Med; 2018 Jun; 57(11):1523-1531. PubMed ID: 29434161
[TBL] [Abstract][Full Text] [Related]
10. The effect of steroid therapy on pancreatic exocrine function in autoimmune pancreatitis.
de Pretis N; Martinelli L; Palmeri E; Caldart F; Crucillà S; Zorzi A; Brillo A; Crinò SF; Conti Bellocchi MC; Bernardoni L; De Marchi G; Amodio A; Campagnola P; Ciccocioppo R; Gabbrielli A; Marcon A; Frulloni L
Pancreatology; 2024 Jun; 24(4):538-544. PubMed ID: 38693038
[TBL] [Abstract][Full Text] [Related]
11. Native T1 mapping of autoimmune pancreatitis as a quantitative outcome surrogate.
Zhu L; Lai Y; Makowski M; Zhang W; Sun Z; Qian T; Nickel D; Hamm B; Asbach P; Duebgen M; Xue H; Jin Z
Eur Radiol; 2019 Aug; 29(8):4436-4446. PubMed ID: 30707275
[TBL] [Abstract][Full Text] [Related]
12. Factors predictive of relapse and spontaneous remission of autoimmune pancreatitis patients treated/not treated with corticosteroids.
Kubota K; Watanabe S; Uchiyama T; Kato S; Sekino Y; Suzuki K; Mawatari H; Iida H; Endo H; Fujita K; Yoneda M; Takahashi H; Kirikoshi H; Kobayashi N; Saito S; Sugimori K; Hisatomi K; Matsuhashi N; Sato H; Tanida E; Sakaguchi T; Fujisawa N; Nakajima A
J Gastroenterol; 2011 Jun; 46(6):834-42. PubMed ID: 21491208
[TBL] [Abstract][Full Text] [Related]
13. Correlation between long-term outcome and steroid therapy in type 1 autoimmune pancreatitis: relapse, malignancy and side effect of steroid.
Shimizu S; Naitoh I; Nakazawa T; Hayashi K; Miyabe K; Kondo H; Nishi Y; Yoshida M; Umemura S; Hori Y; Kato A; Okumura F; Sano H; Hirata Y; Takada H; Ohara H; Joh T
Scand J Gastroenterol; 2015; 50(11):1411-8. PubMed ID: 26061806
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
[TBL] [Abstract][Full Text] [Related]
15. Exocrine and Endocrine Insufficiency in Autoimmune Pancreatitis: A Matter of Treatment or Time?
Nikolic S; Maisonneuve P; Dahlman I; Löhr JM; Vujasinovic M
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807009
[TBL] [Abstract][Full Text] [Related]
16. Persistent enlargement of the pancreatic gland after glucocorticoid therapy increases the risk of relapse in IgG4-related autoimmune pancreatitis.
Lu H; Peng L; Zhu L; Feng R; Zhou J; Liu Z; Li J; Luo X; Peng Y; Qin C; Fei Y; Zhao Y; Zeng X; Lai Y; Zhang W
Clin Rheumatol; 2022 Jun; 41(6):1709-1718. PubMed ID: 35175447
[TBL] [Abstract][Full Text] [Related]
17. Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis.
Li M; Bai X; Xu K; Wu X; Guo T; Jiang Q; Wang Q; Zhang S; Yang Y; Feng Y; Yang A
Hepatobiliary Surg Nutr; 2022 Jun; 11(3):355-362. PubMed ID: 35693390
[TBL] [Abstract][Full Text] [Related]
18. Understanding autoimmune pancreatitis: Clinical features, management challenges, and association with malignancies.
Christodoulidis G; Kouliou MN; Koumarelas KE
World J Gastroenterol; 2024 Apr; 30(15):2091-2095. PubMed ID: 38681985
[TBL] [Abstract][Full Text] [Related]
19. Predominant Improvement of Alpha Cell Function after Steroid Therapy in a Patient with Autoimmune Pancreatitis: Case Report.
Takeshima K; Ariyasu H; Iwakura H; Kawai S; Uraki S; Inaba H; Furuta M; Warigaya K; Murata SI; Akamizu T
Diabetes Ther; 2018 Jun; 9(3):1385-1395. PubMed ID: 29725970
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategy for autoimmune pancreatitis.
Kamisawa T; Satake K
Adv Med Sci; 2008; 53(2):145-8. PubMed ID: 18762470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
